Renjitha Bhaskaran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Renjitha Bhaskaran has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Ajee Kurunjippadath Lakshmanan
Department of Medical Surgical Nursing, Amrita College of Nursing, Amrita Vishwa Vidyapeetham, Health Sciences Campus, Kochi 682041, Kerala, India
2 shared publications - Arya Chandrababu Jaya
Dysphagia Services, Department of Head and Neck Surgery, Amrita Institute of Medical Sciences and Research Centre, Kochi, Kerala, India
2 shared publications - Krishnakumar Thankappan
Department of Head and Neck Surgery and Oncology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India
2 shared publications - Praveen Kerala Varma
Department of Cardio-Thoracic Surgery, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, India
2 shared publications - Premjith Bhavukam
Amrita School of Artificial Intelligence, Coimbatore, Amrita Vishwa Vidyapeetham
2 shared publications - Subramania Iyer
Department of Plastic and Reconstructive Surgery, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham, Kochi, India
2 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (22) , 3714
Development and Internal Validation of a Nurse-Led Sepsis Risk Score Using AI-Enabled Remote Patient Monitoring Data in Adult Febrile Neutropenia: A Nested Case–Control Study
Background/Objectives: Febrile neutropenia (FN) in hematologic malignancies carries a high risk of sepsis. We developed a regression model and a simplified nurse-led sepsis risk score using artificial intelligence (AI)-enabled remote patient monitoring (RPM) measurements and routine clinical and laboratory variables. Methods: A nested case–control study included 120 adult FN episodes (40 Sepsis-3-defined cases within 14 days of FN onset; 80 matched controls) in a hematology/bone marrow transplantation unit (BMT) in India (December 2021–December 2024). Heart rate and respiratory rate were obtained by ballistocardiography; blood pressure (BP), peripheral oxygen saturation (SpO2), and temperature were obtained using connected probes. Only a single set of FN-onset measurements was analyzed; longitudinal RPM trends and platform-generated alerts were excluded. Conditional logistic regression identified independent predictors and supplied coefficients for an integer-weighted score. Regression-model validation used two 1000-resample bootstrap analyses: one holding cut-offs and predictors fixed, the other repeating cut-off determination and backward selection. Integer-score discrimination was assessed separately. Results: Six predictors—tachycardia, hypotension, ≥2 comorbidities, absolute neutrophil count <99.5 cells/μL, chills, and elevated procalcitonin—formed an 8-point score. The regression model area under the receiver operating characteristic curve (AUC) was 0.847, with fixed-specification optimism of 0.028 and a corrected AUC of 0.819. Repeating cut-off determination and predictor selection yielded an apparent AUC of 0.855, optimism of 0.036, and corrected AUC of 0.819. The integer-score apparent AUC was 0.654 (95% CI 0.567–0.740), without optimism correction. Conclusions: Regression-model discrimination remained similar after accounting for cut-off determination and predictor selection. Integer-score performance remains uncorrected for optimism and requires independent temporal validation before clinical use. RPM’s AI functions and continuous-monitoring benefits were not evaluated. Temporal validation is planned in Phase II. Trial registration: Clinical Trials Registry of India (CTRI/2025/06/088290).
- 10 November 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (22) , 3714
Open AccessDevelopment and Internal Validation of a Nurse-Led Sepsis Risk Score Using AI-Enabled Remote Patient Monitoring Data in Adult Febrile Neutropenia: A Nested Case–Control Study
Background/Objectives: Febrile neutropenia (FN) in hematologic malignancies carries a high risk of sepsis. We developed a regression model and a simplified nurse-led sepsis risk score using artificial intelligence (AI)-enabled remote patient monitoring (RPM) measurements and routine clinical and laboratory variables. Methods: A nested case–control study included 120 adult FN episodes (40 Sepsis-3-defined cases within 14 days of FN onset; 80 matched controls) in a hematology/bone marrow transplantation unit (BMT) in India (December 2021–December 2024). Heart rate and respiratory rate were obtained by ballistocardiography; blood pressure (BP), peripheral oxygen saturation (SpO2), and temperature were obtained using connected probes. Only a single set of FN-onset measurements was analyzed; longitudinal RPM trends and platform-generated alerts were excluded. Conditional logistic regression identified independent predictors and supplied coefficients for an integer-weighted score. Regression-model validation used two 1000-resample bootstrap analyses: one holding cut-offs and predictors fixed, the other repeating cut-off determination and backward selection. Integer-score discrimination was assessed separately. Results: Six predictors—tachycardia, hypotension, ≥2 comorbidities, absolute neutrophil count <99.5 cells/μL, chills, and elevated procalcitonin—formed an 8-point score. The regression model area under the receiver operating characteristic curve (AUC) was 0.847, with fixed-specification optimism of 0.028 and a corrected AUC of 0.819. Repeating cut-off determination and predictor selection yielded an apparent AUC of 0.855, optimism of 0.036, and corrected AUC of 0.819. The integer-score apparent AUC was 0.654 (95% CI 0.567–0.740), without optimism correction. Conclusions: Regression-model discrimination remained similar after accounting for cut-off determination and predictor selection. Integer-score performance remains uncorrected for optimism and requires independent temporal validation before clinical use. RPM’s AI functions and continuous-monitoring benefits were not evaluated. Temporal validation is planned in Phase II. Trial registration: Clinical Trials Registry of India (CTRI/2025/06/088290).
- Open Access
- 22 October 2026
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (10) , 1097-1104
Impact of targeted blood pressure management versus standard care amongst high-risk patients undergoing major abdominal surgeries: A pilot study
Background and Aims: Targeting blood pressures closer to the patient’s normal could result in a reduction in post-operative morbidity amongst high-risk patients undergoing abdominal surgery. The study primarily evaluated the impact of targeted mean arterial pressure (MAP) (20% baseline) versus standard care on organ dysfunction. The secondary outcomes assessed were length of intensive care unit (ICU) and hospital stay along with all-cause mortality. Methods: Patients aged 45 years and above with diabetes mellitus, coronary artery, peripheral or cerebral vascular disease ( n = 130) undergoing major abdominal surgeries were randomised to either Group T (targeted MAP, n = 60) or Group S (standard care n = 70) and primary outcomes measured at 24 h. Lengths of ICU stay and hospital stay and all-cause mortality were noted. Results: Post-operative troponins, creatinine, platelet count, international normalised ratio, and cognitive and respiratory outcomes were comparable. The time-weighted average of MAP P = 0.135, while the time spent within the target MAP range was higher in Group T, 91.3% versus 77.8%, P < 0.001. The ICU stay was 3.0 (2–4) vs. 4 (3.2–5) days, P < 0.001, and hospital stay 5 (4–6) vs. 6.0 (5–7) days ( P < 0.001) in Group S vs. Group T, while the mortality was comparable. Conclusion: Targeted blood pressure management in high-risk patients undergoing abdominal surgery did not result in differences in post-operative outcomes in comparison to the standard care. The lengths of ICU and hospital stay were longer in Group T, probably due to the higher risk profile of patients in this group.
- 22 October 2026
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (10) , 1097-1104
Open AccessImpact of targeted blood pressure management versus standard care amongst high-risk patients undergoing major abdominal surgeries: A pilot study
Background and Aims: Targeting blood pressures closer to the patient’s normal could result in a reduction in post-operative morbidity amongst high-risk patients undergoing abdominal surgery. The study primarily evaluated the impact of targeted mean arterial pressure (MAP) (20% baseline) versus standard care on organ dysfunction. The secondary outcomes assessed were length of intensive care unit (ICU) and hospital stay along with all-cause mortality. Methods: Patients aged 45 years and above with diabetes mellitus, coronary artery, peripheral or cerebral vascular disease ( n = 130) undergoing major abdominal surgeries were randomised to either Group T (targeted MAP, n = 60) or Group S (standard care n = 70) and primary outcomes measured at 24 h. Lengths of ICU stay and hospital stay and all-cause mortality were noted. Results: Post-operative troponins, creatinine, platelet count, international normalised ratio, and cognitive and respiratory outcomes were comparable. The time-weighted average of MAP P = 0.135, while the time spent within the target MAP range was higher in Group T, 91.3% versus 77.8%, P < 0.001. The ICU stay was 3.0 (2–4) vs. 4 (3.2–5) days, P < 0.001, and hospital stay 5 (4–6) vs. 6.0 (5–7) days ( P < 0.001) in Group S vs. Group T, while the mortality was comparable. Conclusion: Targeted blood pressure management in high-risk patients undergoing abdominal surgery did not result in differences in post-operative outcomes in comparison to the standard care. The lengths of ICU and hospital stay were longer in Group T, probably due to the higher risk profile of patients in this group.
- Open Access
- 4 August 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e103717
Nurse-Led Large Language Model Chatbot for Predicting and Preventing Complications After Coronary Artery Bypass Grafting: Protocol for a Randomized Controlled Trial
Background: Thirty-day unplanned readmission following coronary artery bypass grafting (CABG) affects 10%-20% of patients and is a key quality indicator, particularly in low- and middle-income countries (LMICs) where access to cardiac rehabilitation is limited. Existing risk models are static, lack real-time engagement, and no validated large language model (LLM)–based clinical decision support (CDS) system exists for post-CABG readmission prevention. Objective: This protocol describes the development, validation, and evaluation of Smart CABGuard, a nurse-led, LLM-based CDS chatbot with continuous remote electrocardiographic (ECG) monitoring, to predict and prevent postoperative complications, and 30-day unplanned readmission after isolated CABG. Methods: This multiphase translational study is conducted at Amrita Institute of Medical Sciences, Kochi, India, following TRIPOD-LLM (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis–Large Language Model) and CONSORT (Consolidated Standards of Reporting Trials) AI reporting guidelines. Phase I uses an ambispective design (retrospective: January 2020 to December 2024; prospective needs survey: June 2025 to January 2026) to develop a logistic regression-based Complication Risk Index (CRI), assessed via receiver operating characteristic area under the curve, Brier score, and decision curve analysis. Phase II refines Smart CABGuard by integrating a frozen Mistral-7B LLM (low-rank adaptation fine-tuned), the CRI engine, explainable AI, and single-lead ECG telemetry (Amrita Spandanam device), with a usability threshold of ≥80%. Phase III is a prospective, parallel-group, open-label randomized controlled trial (RCT). Adults aged ≥18 years undergoing isolated CABG with smartphone access are randomized 1:1 via permuted block randomization, with allocation concealment. The intervention arm receives Smart CABGuard–assisted care (daily chatbot check-ins, CRI-based risk stratification, ECG monitoring, and nurse-led triage) for approximately 24 days postdischarge plus standard care; the control arm receives standard care with structured telephone follow-up for outcome ascertainment only. Outcome assessors and statisticians are blinded; analyses follow the intention-to-treat principle. The primary outcome is 30-day all-cause unplanned readmission. Based on a baseline rate of 10.71%, a 50% relative reduction, α=.10, and 80% power, the target sample size is 800 patients (400 per arm, including 10% attrition). Results: Ethics approval was granted by the Institutional Ethics Committee of Amrita Institute of Medical Sciences on April 16, 2025. Funding was awarded by Sigma Theta Tau International Honor Society of Nursing, Small Grants Program (grant 21650) in June 2025. Phase I data extraction commenced in May 2025 and is projected to be completed by April 2026; the patient needs survey (June 2025 to January 2026) is ongoing. Phase II usability evaluation is projected from May to July 2026. Phase III recruitment is anticipated from August 2026 to September 2027. Results are expected to be published in early 2028. Conclusions: Smart CABGuard is the first RCT protocol of an LLM-based nurse-led CDS system for post-CABG readmission prevention in an LMIC setting, aiming to establish the usefulness, safety, and feasibility of AI-augmented postoperative surveillance.
- 4 August 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e103717
Open AccessNurse-Led Large Language Model Chatbot for Predicting and Preventing Complications After Coronary Artery Bypass Grafting: Protocol for a Randomized Controlled Trial
Background: Thirty-day unplanned readmission following coronary artery bypass grafting (CABG) affects 10%-20% of patients and is a key quality indicator, particularly in low- and middle-income countries (LMICs) where access to cardiac rehabilitation is limited. Existing risk models are static, lack real-time engagement, and no validated large language model (LLM)–based clinical decision support (CDS) system exists for post-CABG readmission prevention. Objective: This protocol describes the development, validation, and evaluation of Smart CABGuard, a nurse-led, LLM-based CDS chatbot with continuous remote electrocardiographic (ECG) monitoring, to predict and prevent postoperative complications, and 30-day unplanned readmission after isolated CABG. Methods: This multiphase translational study is conducted at Amrita Institute of Medical Sciences, Kochi, India, following TRIPOD-LLM (Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis–Large Language Model) and CONSORT (Consolidated Standards of Reporting Trials) AI reporting guidelines. Phase I uses an ambispective design (retrospective: January 2020 to December 2024; prospective needs survey: June 2025 to January 2026) to develop a logistic regression-based Complication Risk Index (CRI), assessed via receiver operating characteristic area under the curve, Brier score, and decision curve analysis. Phase II refines Smart CABGuard by integrating a frozen Mistral-7B LLM (low-rank adaptation fine-tuned), the CRI engine, explainable AI, and single-lead ECG telemetry (Amrita Spandanam device), with a usability threshold of ≥80%. Phase III is a prospective, parallel-group, open-label randomized controlled trial (RCT). Adults aged ≥18 years undergoing isolated CABG with smartphone access are randomized 1:1 via permuted block randomization, with allocation concealment. The intervention arm receives Smart CABGuard–assisted care (daily chatbot check-ins, CRI-based risk stratification, ECG monitoring, and nurse-led triage) for approximately 24 days postdischarge plus standard care; the control arm receives standard care with structured telephone follow-up for outcome ascertainment only. Outcome assessors and statisticians are blinded; analyses follow the intention-to-treat principle. The primary outcome is 30-day all-cause unplanned readmission. Based on a baseline rate of 10.71%, a 50% relative reduction, α=.10, and 80% power, the target sample size is 800 patients (400 per arm, including 10% attrition). Results: Ethics approval was granted by the Institutional Ethics Committee of Amrita Institute of Medical Sciences on April 16, 2025. Funding was awarded by Sigma Theta Tau International Honor Society of Nursing, Small Grants Program (grant 21650) in June 2025. Phase I data extraction commenced in May 2025 and is projected to be completed by April 2026; the patient needs survey (June 2025 to January 2026) is ongoing. Phase II usability evaluation is projected from May to July 2026. Phase III recruitment is anticipated from August 2026 to September 2027. Results are expected to be published in early 2028. Conclusions: Smart CABGuard is the first RCT protocol of an LLM-based nurse-led CDS system for post-CABG readmission prevention in an LMIC setting, aiming to establish the usefulness, safety, and feasibility of AI-augmented postoperative surveillance.
- 18 May 2026
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 78 (6) , 3398-3407
Evaluation of Dysphagia in Pre and Post-Resection of Posterior Fossa Tumors: A Retrospective Study
- 18 May 2026
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 78 (6) , 3398-3407
Evaluation of Dysphagia in Pre and Post-Resection of Posterior Fossa Tumors: A Retrospective Study
- 12 May 2026
- Published by Taylor & Francis in Applied Neuropsychology: Adult
- p. 1-12
Neuropsychological functioning and emotional processing in acoustic schwannoma: Insights from an Indian cohort
Benign brain tumors are low-grade, non-cancerous, slow-growing masses of cells that typically remain within a specific region of the brain (Khan et al., 2020) and commonly occur in the meninges (me...
- 12 May 2026
- Published by Taylor & Francis in Applied Neuropsychology: Adult
- p. 1-12
Neuropsychological functioning and emotional processing in acoustic schwannoma: Insights from an Indian cohort
Benign brain tumors are low-grade, non-cancerous, slow-growing masses of cells that typically remain within a specific region of the brain (Khan et al., 2020) and commonly occur in the meninges (me...
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Food Science
- Vol. 2026 (1) , 6568539
Urban Consumer Behaviors in Kochi, India: Food Choice Motivations, Food Label Literacy, and Nutrition Panel Use
As consumer preferences shift, a nutritional revolution marked by increased consumption of energy‐dense processed foods is driving a rise in chronic, noncommunicable diseases. Factors influencing food purchasing behaviors were assessed among the urban population of Kochi, India. A community‐based cross‐sectional survey was conducted among 680 participants aged 18–60 years. Health benefits, convenience, and sensory appeal were found to be the most significant factors considered while purchasing packaged food. Participants who were younger ( p = 0.002), female ( p = 0.011), and/or had at least one reported comorbidity ( p = 0.010) were significantly more concerned with the food′s sensory appeal, while participants from lower socioeconomic backgrounds were significantly more likely to consider price ( p = 0.007). Furthermore, consumers who placed importance on the natural content and health‐promoting aspects of food were significantly more likely to have food label literacy ( p < 0.05) and/or use nutrition panels ( p < 0.05). Participants with higher food label literacy were more likely to use nutrition panels ( p = 0.017, adjusted R 2 : 0.017). These findings underscore the importance of tailoring public health interventions to demographic‐specific motivations. Community‐based educational interventions shown to improve food label literacy and utilization may help promote individual consideration of natural and health‐promoting aspects of food products while shopping, which is associated with healthier food consumption patterns.
- 1 January 2026
- Published by Wiley in International Journal of Food Science
- Vol. 2026 (1) , 6568539
Open AccessUrban Consumer Behaviors in Kochi, India: Food Choice Motivations, Food Label Literacy, and Nutrition Panel Use
As consumer preferences shift, a nutritional revolution marked by increased consumption of energy‐dense processed foods is driving a rise in chronic, noncommunicable diseases. Factors influencing food purchasing behaviors were assessed among the urban population of Kochi, India. A community‐based cross‐sectional survey was conducted among 680 participants aged 18–60 years. Health benefits, convenience, and sensory appeal were found to be the most significant factors considered while purchasing packaged food. Participants who were younger ( p = 0.002), female ( p = 0.011), and/or had at least one reported comorbidity ( p = 0.010) were significantly more concerned with the food′s sensory appeal, while participants from lower socioeconomic backgrounds were significantly more likely to consider price ( p = 0.007). Furthermore, consumers who placed importance on the natural content and health‐promoting aspects of food were significantly more likely to have food label literacy ( p < 0.05) and/or use nutrition panels ( p < 0.05). Participants with higher food label literacy were more likely to use nutrition panels ( p = 0.017, adjusted R 2 : 0.017). These findings underscore the importance of tailoring public health interventions to demographic‐specific motivations. Community‐based educational interventions shown to improve food label literacy and utilization may help promote individual consideration of natural and health‐promoting aspects of food products while shopping, which is associated with healthier food consumption patterns.
- Open Access
- 15 May 2025
- Published by Wolters Kluwer Health in Formosan Journal of Surgery
- Vol. 58 (5) , 200-203
Pilot of a randomized prospective observational study of vitamin D deficiency as a predictor of postoperative hypocalcemia in a cohort of patients undergoing total thyroidectomy
Background: Temporary hypocalcemia is common following total thyroidectomy hypocalcemia and is attributed to inadvertent parathyroid gland injury or ischemia. This postoperative hypocalcemia may be made worse by the disturbance of calcium metabolism brought on by vitamin D insufficiency (VDD). Materials and Methods: A prospective randomized observational pilot study was conducted at a tertiary care hospital in South India. In this study, 29 patients were categorized by preoperative vitamin D levels into 3 groups: group A (normal vitamin D), group B (deficient but supplemented), and group C (deficient without supplementation). Corrected calcium was evaluated daily for postoperative biochemical hypocalcemia along with clinical features of hypocalcemia. Data were recorded and statistically analyzed. Chi-square tests were used to evaluate associations. Results: Postoperative hypocalcemia was significantly higher in patients with preoperative vitamin D deficiency, group C (p < 0.003), compared to groups A and B. Preoperative supplementation significantly reduced hypocalcemia rates in group B. Conclusions: The pilot study shows a significant association between vitamin D deficiency and postoperative hypocalcemia following total thyroidectomy. Patients with preoperative vitamin D deficiency, especially without supplementation, are at higher risk. Early identification and correction of vitamin D deficiency may mitigate the incidence of postoperative hypocalcemia, thereby potentially improving patient outcomes and reducing healthcare costs.
- 15 May 2025
- Published by Wolters Kluwer Health in Formosan Journal of Surgery
- Vol. 58 (5) , 200-203
Open AccessPilot of a randomized prospective observational study of vitamin D deficiency as a predictor of postoperative hypocalcemia in a cohort of patients undergoing total thyroidectomy
Background: Temporary hypocalcemia is common following total thyroidectomy hypocalcemia and is attributed to inadvertent parathyroid gland injury or ischemia. This postoperative hypocalcemia may be made worse by the disturbance of calcium metabolism brought on by vitamin D insufficiency (VDD). Materials and Methods: A prospective randomized observational pilot study was conducted at a tertiary care hospital in South India. In this study, 29 patients were categorized by preoperative vitamin D levels into 3 groups: group A (normal vitamin D), group B (deficient but supplemented), and group C (deficient without supplementation). Corrected calcium was evaluated daily for postoperative biochemical hypocalcemia along with clinical features of hypocalcemia. Data were recorded and statistically analyzed. Chi-square tests were used to evaluate associations. Results: Postoperative hypocalcemia was significantly higher in patients with preoperative vitamin D deficiency, group C (p < 0.003), compared to groups A and B. Preoperative supplementation significantly reduced hypocalcemia rates in group B. Conclusions: The pilot study shows a significant association between vitamin D deficiency and postoperative hypocalcemia following total thyroidectomy. Patients with preoperative vitamin D deficiency, especially without supplementation, are at higher risk. Early identification and correction of vitamin D deficiency may mitigate the incidence of postoperative hypocalcemia, thereby potentially improving patient outcomes and reducing healthcare costs.
- 18 October 2023
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 40 (2) , 133-141
Early and long-term outcomes of mitral valve replacement with mechanical valve in rheumatic heart disease
Background Rheumatic fever and rheumatic heart disease is endemic in India. Mitral valve replacement with mechanical valve is the commonest surgical procedure performed in rheumatic heart disease (RHD). However, there are no studies reporting the long-term outcomes of mechanical mitral valve replacement in rheumatic heart disease from India. Objective The primary objective of the study was to look at the long-term survival following mechanical mitral valve replacement in RHD. The secondary objectives included follow up complications and event-free survival. Methods For this study, 238 patients who underwent mitral valve replacement with TTK Chitra™ valve from 1st January 2006 to 31st December 2018 for RHD were included for analysis and reporting. The median follow-up period was 3371.50 days (9.3 years). Total follow-up was 2044 patient-years. Results The mean age of the study population was 39.72 ± 10.48 years (range: 18–68 years). Out of 238 patients operated, 155 patients (65.12%) were alive and 69 patients (28.99%) were dead, and 14 patients (5.88%) were lost to follow-up. The operative mortality was 6 (2.52%) and the follow-up mortality was 63 (26.47%). The reasons for follow-up mortality were cardiac complications in 22 (34.9%) patients, valve-related complications in 18 (28.5%) patients, sudden unexplained death in 13 (20.6%) patients, and non-valve/ non-cardiac death in 10patients (15.8%). The one-year survival was 94.0%, five-year survival was 83.6%, ten-year survival was 70.6% and 15-year survival was 62.9%. During follow-up, valve-related events occurred in 123(52%) patients. The 15-year event-free survival was 33.0%. Conclusions The long term outcome of mechanical valve replacement of the mitral valve in RHD patients was less than favorable. Both cardiac complications and mechanical valve related complications reduced their survival.
- 18 October 2023
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 40 (2) , 133-141
Early and long-term outcomes of mitral valve replacement with mechanical valve in rheumatic heart disease
Background Rheumatic fever and rheumatic heart disease is endemic in India. Mitral valve replacement with mechanical valve is the commonest surgical procedure performed in rheumatic heart disease (RHD). However, there are no studies reporting the long-term outcomes of mechanical mitral valve replacement in rheumatic heart disease from India. Objective The primary objective of the study was to look at the long-term survival following mechanical mitral valve replacement in RHD. The secondary objectives included follow up complications and event-free survival. Methods For this study, 238 patients who underwent mitral valve replacement with TTK Chitra™ valve from 1st January 2006 to 31st December 2018 for RHD were included for analysis and reporting. The median follow-up period was 3371.50 days (9.3 years). Total follow-up was 2044 patient-years. Results The mean age of the study population was 39.72 ± 10.48 years (range: 18–68 years). Out of 238 patients operated, 155 patients (65.12%) were alive and 69 patients (28.99%) were dead, and 14 patients (5.88%) were lost to follow-up. The operative mortality was 6 (2.52%) and the follow-up mortality was 63 (26.47%). The reasons for follow-up mortality were cardiac complications in 22 (34.9%) patients, valve-related complications in 18 (28.5%) patients, sudden unexplained death in 13 (20.6%) patients, and non-valve/ non-cardiac death in 10patients (15.8%). The one-year survival was 94.0%, five-year survival was 83.6%, ten-year survival was 70.6% and 15-year survival was 62.9%. During follow-up, valve-related events occurred in 123(52%) patients. The 15-year event-free survival was 33.0%. Conclusions The long term outcome of mechanical valve replacement of the mitral valve in RHD patients was less than favorable. Both cardiac complications and mechanical valve related complications reduced their survival.
- Open Access
- 31 July 2023
- Published by IP Innovative Publication Pvt Ltd in Panacea Journal of Medical Sciences
- Vol. 13 (2) , 323-327
Does vitamin D play a role in uterine fibroids? A case control study
Introduction: Uterine fibroids are monoclonal tumors of uterine smooth muscle cells. They are found in 20-40% of females in the reproductive age group. Ovarian hormones play an important role in its etiology. Recent studies have shown that low serum 25(OH)vitamin D levels are associated with increased risk of uterine fibroids.Aim: To investigate the association between serum vitamin D levels and uterine fibroids.Materials and Methods: A case control study was conducted in a tertiary care hospital among 183 women between the age of 18-50 years with uterine fibroids who attended obstetrics and gynecology department and 183 women of the same age group who had no uterine fibroids attending comprehensive health checkup clinic. Serum 25(OH)vitamin D levels were estimated in both groups by electrochemiluminescence immunoassay.
- 31 July 2023
- Published by IP Innovative Publication Pvt Ltd in Panacea Journal of Medical Sciences
- Vol. 13 (2) , 323-327
Open AccessDoes vitamin D play a role in uterine fibroids? A case control study
Introduction: Uterine fibroids are monoclonal tumors of uterine smooth muscle cells. They are found in 20-40% of females in the reproductive age group. Ovarian hormones play an important role in its etiology. Recent studies have shown that low serum 25(OH)vitamin D levels are associated with increased risk of uterine fibroids.Aim: To investigate the association between serum vitamin D levels and uterine fibroids.Materials and Methods: A case control study was conducted in a tertiary care hospital among 183 women between the age of 18-50 years with uterine fibroids who attended obstetrics and gynecology department and 183 women of the same age group who had no uterine fibroids attending comprehensive health checkup clinic. Serum 25(OH)vitamin D levels were estimated in both groups by electrochemiluminescence immunoassay.
- 10 October 2022
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 14 (1) , 208-214
Fall in Ki67 Index After Short-Term Preoperative Letrozole: a Gateway to Assess the Response in Hormone-Positive Early Breast Cancers
Endocrine treatment for breast cancer acts largely by inhibiting tumor cell proliferation. The study aimed to explore the fall in proliferative marker Ki67 in patients receiving preoperative endocrine therapy and the factors associated with it. A prospective series of hormone receptor-positive postmenopausal women with early N0/N1 breast cancer were enrolled. Patients were requested to take letrozole OD while they await surgery. The fall in Ki67 after the endocrine therapy was defined as the percentage of the difference between the pre-and postoperative Ki67 value with the preoperative Ki67. Sixty cases matched the criteria of which 41 (68.3%) of women showed a good response to preoperative letrozole (fall in Ki67 > 50%; p-value < 0.001). The average mean fall in Ki67 was 57.083 ± 37.97. Postoperative Ki67 after the therapy was less than 10% in 39 (65%) patients. Ten patients (16.6%) had a low Ki67 index at baseline, which continued to remain low after preoperative endocrine therapy. The duration of the therapy did not affect the percentage of Ki67 fall in our study. Short-term changes in the Ki67 index in the neoadjuvant settings may predict outcomes during adjuvant use of the same treatment. Proliferation index on residual tumor holds prognostic importance, and our results reflect that greater attention should be given to the percentage of reduction of Ki67, rather than focusing purely on a fixed value. This could help predict patients who respond well to endocrine therapy, while those who respond poorly may require further adjuvant treatment.
- 10 October 2022
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 14 (1) , 208-214
Fall in Ki67 Index After Short-Term Preoperative Letrozole: a Gateway to Assess the Response in Hormone-Positive Early Breast Cancers
Endocrine treatment for breast cancer acts largely by inhibiting tumor cell proliferation. The study aimed to explore the fall in proliferative marker Ki67 in patients receiving preoperative endocrine therapy and the factors associated with it. A prospective series of hormone receptor-positive postmenopausal women with early N0/N1 breast cancer were enrolled. Patients were requested to take letrozole OD while they await surgery. The fall in Ki67 after the endocrine therapy was defined as the percentage of the difference between the pre-and postoperative Ki67 value with the preoperative Ki67. Sixty cases matched the criteria of which 41 (68.3%) of women showed a good response to preoperative letrozole (fall in Ki67 > 50%; p-value < 0.001). The average mean fall in Ki67 was 57.083 ± 37.97. Postoperative Ki67 after the therapy was less than 10% in 39 (65%) patients. Ten patients (16.6%) had a low Ki67 index at baseline, which continued to remain low after preoperative endocrine therapy. The duration of the therapy did not affect the percentage of Ki67 fall in our study. Short-term changes in the Ki67 index in the neoadjuvant settings may predict outcomes during adjuvant use of the same treatment. Proliferation index on residual tumor holds prognostic importance, and our results reflect that greater attention should be given to the percentage of reduction of Ki67, rather than focusing purely on a fixed value. This could help predict patients who respond well to endocrine therapy, while those who respond poorly may require further adjuvant treatment.